HIKMA PHARMACEUTICALS PLC ORD S - stock earnings
HIK.L Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q2 | 10.4 billion GBp | 113.0 billion GBp |
2023Q1 | 65.5 million USD | 713.5 million USD |
2022Q4 | 1.2 billion GBp | 107.8 billion GBp |
2022Q3 | 4.3 billion GBp | 56.6 billion GBp |
2022Q2 | 14.2 billion GBp | 99.8 billion GBp |
2022Q1 | 3.6 billion GBp | 48.0 billion GBp |
2021Q4 | 12.8 billion GBp | 98.9 billion GBp |
2021Q3 | 86.5 million GBp | 668.5 million GBp |
2021Q2 | 17.9 billion GBp | 87.9 billion GBp |
2020Q4 | 16.0 billion GBp | 88.4 billion GBp |
2020Q2 | 17.1 billion GBp | 91.3 billion GBp |
2019Q4 | 23.0 billion GBp | 88.5 billion GBp |
2019Q3 | 12.2 billion GBp | 46.9 billion GBp |
2019Q2 | 7.3 billion GBp | 41.3 billion GBp |
2019Q1 | 7.1 billion GBp | 40.1 billion GBp |
2018Q4 | 6.9 billion GBp | 42.6 billion GBp |
2018Q3 | 6.7 billion GBp | 41.3 billion GBp |
2018Q2 | 4.1 billion GBp | 37.8 billion GBp |
2018Q1 | 3.8 billion GBp | 35.2 billion GBp |
2017Q4 | -33.9 billion GBp | 39.8 billion GBp |
2017Q3 | -34.0 billion GBp | 39.8 billion GBp |
2017Q2 | 2.7 billion GBp | 34.7 billion GBp |
2017Q1 | 2.8 billion GBp | 36.1 billion GBp |
2016Q4 | 3.9 billion GBp | 44.8 billion GBp |
2016Q3 | 3.7 billion GBp | 42.7 billion GBp |
2016Q2 | ? GBp | 32.7 billion GBp |
2016Q1 | ? GBp | 30.7 billion GBp |
2015Q4 | ? GBp | 24.7 billion GBp |
2015Q3 | ? GBp | 24.1 billion GBp |
2015Q2 | ? GBp | 22.5 billion GBp |
2015Q1 | ? GBp | 23.9 billion GBp |
2014Q4 | ? GBp | 24.7 billion GBp |
2014Q3 | ? GBp | 23.7 billion GBp |
2014Q2 | ? GBp | 21.7 billion GBp |
2014Q1 | ? GBp | 22.2 billion GBp |
2013Q4 | ? GBp | 23.7 billion GBp |
2013Q3 | ? GBp | 23.5 billion GBp |
2013Q2 | ? GBp | 20.9 billion GBp |
2013Q1 | ? GBp | 21.0 billion GBp |
2012Q4 | ? GBp | 18.1 billion GBp |
2012Q3 | ? GBp | 18.1 billion GBp |
2012Q2 | ? GBp | 17.1 billion GBp |
2012Q1 | ? GBp | 16.7 billion GBp |
2011Q4 | ? GBp | 17.3 billion GBp |
2011Q3 | ? GBp | 17.1 billion GBp |
2011Q2 | ? GBp | 12.3 billion GBp |
2011Q1 | ? GBp | 12.3 billion GBp |
2010Q4 | ? GBp | 12.6 billion GBp |
2010Q3 | ? GBp | 12.3 billion GBp |
2010Q2 | ? GBp | 12.0 billion GBp |
2010Q1 | ? GBp | 11.8 billion GBp |
2009Q4 | ? GBp | 9.9 billion GBp |
2009Q3 | ? GBp | 10.0 billion GBp |
2009Q2 | ? GBp | 9.8 billion GBp |
2009Q1 | ? GBp | 11.2 billion GBp |
2008Q4 | ? GBp | 9.6 billion GBp |
2008Q3 | ? GBp | 7.9 billion GBp |
2008Q2 | ? GBp | 7.5 billion GBp |
2008Q1 | ? GBp | 7.6 billion GBp |
2007Q4 | ? GBp | 5.7 billion GBp |
2007Q3 | ? GBp | 5.5 billion GBp |
2007Q2 | ? GBp | 5.6 billion GBp |
2007Q1 | ? GBp | 5.7 billion GBp |
2006Q4 | ? GBp | 4.2 billion GBp |
2006Q3 | ? GBp | 4.4 billion GBp |
2006Q2 | ? GBp | 4.2 billion GBp |
2006Q1 | ? GBp | 4.5 billion GBp |
2005Q4 | ? GBp | 3.8 billion GBp |
2005Q3 | ? GBp | 3.7 billion GBp |
2005Q2 | ? GBp | 3.7 billion GBp |
2005Q1 | ? GBp | 3.5 billion GBp |
HIK.L Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 14.9 billion GBp | 225.7 billion GBp |
2022 | 15.5 billion GBp | 208.0 billion GBp |
2021 | 31.1 billion GBp | 188.8 billion GBp |
2020 | 31.5 billion GBp | 171.2 billion GBp |
2019 | 37.1 billion GBp | 168.3 billion GBp |
2018 | 22.2 billion GBp | 163.1 billion GBp |
2017 | -62.7 billion GBp | 144.0 billion GBp |
2016 | 12.6 billion GBp | 158.0 billion GBp |
2015 | 17.0 billion GBp | 97.2 billion GBp |
2014 | 17.9 billion GBp | 95.6 billion GBp |
2013 | 12.9 billion GBp | 82.7 billion GBp |
2012 | 6.2 billion GBp | 68.4 billion GBp |
2011 | 5.2 billion GBp | 59.5 billion GBp |
2010 | 6.4 billion GBp | 47.3 billion GBp |
2009 | 4.8 billion GBp | 39.4 billion GBp |
2008 | 3.9 billion GBp | 39.8 billion GBp |
2007 | 3.2 billion GBp | 22.6 billion GBp |
2006 | 2.8 billion GBp | 16.2 billion GBp |
2005 | 2.5 billion GBp | 15.2 billion GBp |
2004 | 1.9 billion GBp | 11.0 billion GBp |
2003 | 983.1 million GBp | 5.9 billion GBp |
2002 | 653.1 million GBp | 5.3 billion GBp |
HIK.L
Price: £19.38
Dividend Yield: 0.00%
Forward Dividend Yield: 4.87%
Payout Ratio: 17735.85%
Dividend Per Share: 94.00 GBp
Earnings Per Share: 0.68 GBp
P/E Ratio: 36.95
Exchange: LSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 18421
Market Capitalization: 4.0 billion
Average Dividend Frequency: 2
Years Paying Dividends: 19
DGR3: -5.62%
DGR5: 19.58%
DGR10: 30.00%